STOCK TITAN

Fate Therapeutics, Inc. (FATE) Revenue by Year

FATE

Fate Therapeutics, Inc. generated $6.6M in revenue in fiscal year 2025. This represents a decrease of 51.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $6.5M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Fate Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $6.6M
YoY -51.2%
5Y CAGR -26.7%
10Y CAGR +10.6%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

FATE Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$6.5M$6.6M-51.2%$13.6M-78.5%$63.5M-34.0%$96.3M+72.4%$55.8M+77.7%$31.4M+194.3%$10.7M+125.3%$4.7M+15.4%$4.1M-6.7%$4.4M+81.1%$2.4MN/A$971K-63.6%$2.7M+128.2%$1.2M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

FATE Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$2.1M+9.2%$1.3M-20.3%$1.4M-26.4%$1.7M-43.4%$1.9M-71.8%$1.6M-15.4%$1.9M+11.0%$3.1M+58.1%$6.8M+625.8%$1.9M-96.7%$1.7M-96.2%$1.9M-87.0%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Fate Therapeutics, Inc. financials

Frequently Asked Questions

What was Fate Therapeutics, Inc.'s revenue in fiscal year 2025?

Fate Therapeutics, Inc. generated $6.6M in revenue in fiscal year 2025.

How fast is Fate Therapeutics, Inc.'s revenue growing?

Fate Therapeutics, Inc. (FATE) revenue fell by 51.2% year over year, from $13.6M to $6.6M in fiscal year 2025.

What is Fate Therapeutics, Inc.'s revenue over the last twelve months?

Fate Therapeutics, Inc. (FATE) reported $6.5M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Fate Therapeutics, Inc. (FATE) revenue went from $1.2M in fiscal year 2011 to $6.6M in fiscal year 2025.

Fate Therapeutics, Inc. (FATE) reported $2.1M in revenue in Q2 2026. This represents an increase of 9.2% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Fate Therapeutics, Inc. (FATE) reported on that line in every period on record.